glp 1 euglycemic dka GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | Severe euglycemic ketoacidosis

Heart palpitations can occur during GLP-1 therapy, but understanding the mechanisms and proper monitoring helps minimize risk

Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children

in patients with knee osteoarthritis and type 2 diabetes if treatment is sustained for a sufficient period, according to data.The researchers, who published their findings in the Annals of the Rheumatic Diseases, added that the result may be mediated by weight loss.

Notwithstanding the buzz surrounding the novel weight loss treatments, which is vividly playing out on social media and beyond, capturing this commercial opportunity will still require an orderly, rigorous approach to create and shape a new market

Purpose of Review Obesity pharmacotherapy has become increasingly relevant in older adults due to challenges in lifestyle modification and the burden of non-communicable diseases

One editor details her experience doing the F45 challenge for 8 weeks and gives her review of the program.